Hamilton Health Sciences Corporation: Hemorrhage trials
The registry lists 10 Hemorrhage studies with Hamilton Health Sciences Corporation as lead sponsor. 2 are open to participants now and 0 have results posted.
Phase 3 5Phase 4 1No phase 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Decreasing Postoperative Blood Loss and Seizures by Timing of Intravenous Tranexamic Acid 2 Pilot TrialNot yet recruitingNCT06622564Phase 3
- Bleeding Reduction in Acute and Chronic Kidney Patients Having Surgery (BRACKETS) Pilot TrialRecruitingNCT06337838Phase 3
- Use of Tissue Plasminogen Activator in the Clearance of Chronic Subdural HematomasCompletedNCT05491356Phase 4
- Processed Residual Pump Blood in Cardiac Surgery: The PRBC TrialCompletedNCT01173822Not applicable
- Warfarin After Anterior ST-Elevation Myocardial InfarctionCompletedNCT00662467Not applicable
- Strategies for Transfusion of Platelets (SToP)TerminatedNCT00420914Phase 3
- Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting: The PAPA CABG StudyCompletedNCT00330772Phase 3
- Pilot Bleeding Study: Risk and Protective Factors Associated With Bleeding in the Hemodialysis PopulationStatus unknownNCT00182117
- Long Study - Longitudinal Thrombosis in End Stage Renal DiseaseStatus unknownNCT00157664
- Access II - Trial of Warfarin to Prevent Malfunction of Haemodialysis CathetersCompletedNCT00157651Phase 3